Nitrogen containing heterocyclic rings with a piperazine group are valuable target compounds in medicinal chemistry due to their diversified biological activities. In recent years, many organocatalytic/metal free synthetic pathways towards bisindolylmethanes have been reported. [1] [2] [3] In the present work, we combined bisindolylmethanes with arylpiperazines using hydrophobic moiety (alkyl chain) to obtain heterocycles that can be evaluated in pharmacologically and may be more active than the already active bisindolylmethane alkaloids.
Introduction
Bisindolylmethanes constitute an important class of heterocyclic compounds containing an indole ring and exhibiting a variety of pharmacological activities such as antifungal, antihyperglycemic, anti-inflammatory, antibacterial, anti-cancer, antimicrobial and anti-leishmanial activities, including enzyme inhibition activity. [4] [5] [6] [7] Some of them are accountable for beneficial estrogen metabolism and induce apoptosis in cancer cells of human. 8 They also exhibit inhibitory activity against bladder cancer 9 and renal cell carcinoma growth 10 and inhibit lung 11 and colon cancers. 12 Some bisindolylmethanes showed carbonic anhydrase II inhibitor. 13 On the other hand, dietary nature indoles like 3,3′-diindolylmethane 14 that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. The most common method for the synthesis of BIMs involves consecutive nucleophilic addition of two molecules of indole (nucleophile) to an aldehyde (electrophile) as a one-pot reaction in the presence of a number of catalysts like Brønsted, Lewis acids such as LiClO 4 , In(OTf) 3 , Dy(OTf) 3 , Sc(OTf) 3 , CAN, ZrOCl 2 , InCl 3 , heteropoly acids, ionic liquids, surfactants.
Conclusions
It is well known that bisindoylmethane alkoloids have shown a wide spectrum of pharmacological activities that have been successfully screened for especially anti-cancer, antimicrobial, anti-inflammatory, antiviral and anti-leishmanial activities. On the other hand, aryl piperazines themselves are currently used as medicines and exhibit a wide range of activity in combination with various groups. Herein, we combined two important groups, bisindolylmethane and aryl piperazine with a hydrophobic chain for future activity studies. We anticipate significant biological activity from these substrates.
Experimental Section
General. All reagents were purchased from Aldrich or Merck and were used without further purification. The solvents were dried and distilled according to standard procedures. All melting points were determined on a Gallenkamp digital thermometer, are uncorrected. Reactions were monitored using TLC. Visualizations of the chromatograms were performed either with UV light or vanillin stain. IR spectra were obtained with a Perkin Elmer Spectrum One FTIR Spectrometer and are reported in terms of the frequency of absorption (cm -1 ). 1 H NMR and 13 C NMR spectra were recorded on a Bruker Avance III-500
MHz NMR spectrometer relative to tetramethylsilane (δ = 0.00 ppm), with coupling constant (J) values in Hertz (Hz). Peak multiplicities are designated by the following abbreviations: s, singlet; d, doublet; dd, double doublet; t, triplet; pt, pentet; dt, double triplet; m, multiplet; br, broad. Mass spectra were measured on an Agilent 6890N/5973 GC/IMSD system or LCMS 6400 Series Triple Quadrupole B.08.02 (B8260.0). Highresolution mass spectra were acquired in the positive ion mode using an Agilent G6530B TOF/Qtof Mass spectrometer.
General procedure for synthesis of compounds (3 -6). Compound 2 (2 mmol), aromatic aldehyde (1 mmol) (p-chlorobenzaldehyde, p-fluorobenzaldehyde, phenanthrene-9-carboxaldehyde or 2-naphthaldehyde, respectively) and 1,3-dibromo-5,5-dimethyl hydantoin (DBDMH) (0.005 mmol) were stirred at 55 o C for 16 hours without any solvent. After completion of the reaction with TLC control, crude products were purified by column chromatography. Chlorophenyl)methylene)bis(1-(4-bromobutyl)-1H-indole) (3) . Pink solid (438 mg, 70% isolated yield). mp 50 °C. R f = 0.58 (1:5, ethyl acetate/n-hexane General procedure for synthesis of compounds (7 -10). To a solution of the indole (3 mmol) and aryl aldehyde (1 mmol) in MeCN (2.5 mL) was added a solution of AuCl 3 (1 mol%) in MeCN (1 mL) under an atmosphere of nitrogen. After stirring the reaction mixture at r.t. for 12 h, it was filtered to remove insoluble General procedure for synthesis of compounds (11 -13). A mixture of compound 3, 5 or 6 (1 mmol), 1-(2,3-dichlorophenyl)piperazine hydrochloride (2 mmol), and anhydrous K 2 CO 3 (2 mmol) in MEK (50 mL) was heated at 80 o C for 16 h. After completion of the reaction with TLC control, the solvent was evaporated and the residue was purified by column chromatography using ethyl acetate/n-hexane as the eluent to give pure products 11, 12 or 13. 1-(4-Bromobutyl)-3-((4-chlorophenyl)(1-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-1H-indol-3-yl)methyl)-1H-indole (11 Bromobutyl)-3-((1-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-1H-indol-3-yl) 
3,3'-((4-

1-(4-Bromobutyl)-3-((1-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-1H-indol-3-yl)(phenanthren-9-yl)methyl)-1H-indole (12).
1-(4-
(CAr), 125.6 (CAr), 126.6 (CAr), 127.4 (2xCAr), 127.5 (CAr), 127.6 (2xC), 127.7 (CAr), 127.8 (CAr), 127.9 (CAr), 128.2 (CAr), 130.0 (CAr), 132.2 (C), 133.5 (C), 133.9 (C), 136.6 (2xC), 141.9 (C), 151.2 (2xC
General procedure for synthesis of compounds (14 and 15).
A mixture of compound 3 or 4 (1 mmol), 2-(piperazin-1-yl)pyrimidine (2 mmol), and anhydrous K 2 CO 3 (2 mmol) in MEK (50 mL) was heated at 80 o C for 20 h. After completion of the reaction with TLC control, the solvent was evaporated and the residue was purified by column chromatography using ethyl acetate/n-hexane (30:1) as the eluent to give pure products 14 or 15. 1-(4-Bromobutyl)-3-((4-chlorophenyl)(1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-1H-indol-3-yl)methyl)-1H-indole (14) . Red solid (372 mg, 52.6% isolated yield). mp 64 °C. R f = 0.22 (10:1, ethyl acetate/n-hexane 
1-(4-Bromobutyl)-3-((4-fluorophenyl)(1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-1H-indol-3-yl)methyl)-1H-indole (15
Synthesis of 1-(4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)butyl)-1H-indole (16).
A mixture of compound 2 (252.15 mg, 1 mmol), 1-(3-(trifluoromethyl)phenyl)piperazine (535.2 mg, 1 mmol), and anhydrous K 2 CO 3 (276 mg, 2 mmol) in MEK (10 mL) was heated at 80 o C for 16 h. After completion of the reaction with TLC control, the solvent was evaporated and the residue was purified by column chromatography using ethyl acetate/n-hexane (1:1) as the eluent to give pure product 16 [15] . White solid (300 mg, 75% isolated yield (1-(4-(4-(3-8trifluoromethyl)phenyl)piperazin-1-yl) 
Synthesis of 3,3'-(Phenylmethylene)bis
